Intuitive Surgical (NASDAQ:ISRG) Upgraded by Wall Street Zen to “Buy” Rating

Wall Street Zen upgraded shares of Intuitive Surgical (NASDAQ:ISRG) from a hold rating to a buy rating in a report released on Saturday morning.

Several other analysts have also recently weighed in on ISRG. Argus dropped their price objective on shares of Intuitive Surgical from $630.00 to $560.00 and set a “buy” rating for the company in a research note on Wednesday, February 4th. Zacks Research cut shares of Intuitive Surgical from a “strong-buy” rating to a “hold” rating in a research note on Monday, March 30th. Barclays set a $651.00 price objective on shares of Intuitive Surgical and gave the stock an “overweight” rating in a research note on Thursday, April 23rd. The Goldman Sachs Group lifted their price objective on shares of Intuitive Surgical from $609.00 to $621.00 and gave the stock a “buy” rating in a research note on Wednesday, April 22nd. Finally, TD Cowen dropped their price objective on shares of Intuitive Surgical from $660.00 to $585.00 and set a “buy” rating for the company in a research note on Wednesday, April 22nd. Eighteen investment analysts have rated the stock with a Buy rating, seven have given a Hold rating and one has issued a Sell rating to the stock. According to data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and an average target price of $581.91.

Intuitive Surgical Stock Performance

Shares of ISRG stock opened at $421.12 on Friday. The company has a market capitalization of $149.14 billion, a price-to-earnings ratio of 51.04, a PEG ratio of 3.36 and a beta of 1.51. The company has a 50-day simple moving average of $463.63 and a 200 day simple moving average of $514.04. Intuitive Surgical has a 52 week low of $417.74 and a 52 week high of $603.88.

Intuitive Surgical (NASDAQ:ISRG) last announced its earnings results on Tuesday, April 21st. The medical equipment provider reported $2.50 EPS for the quarter, topping the consensus estimate of $2.08 by $0.42. The business had revenue of $2.77 billion during the quarter, compared to the consensus estimate of $2.62 billion. Intuitive Surgical had a net margin of 28.15% and a return on equity of 15.98%. Intuitive Surgical’s revenue was up 23.0% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $1.81 EPS. Sell-side analysts forecast that Intuitive Surgical will post 8.57 EPS for the current year.

Insider Activity

In other news, SVP Mark Brosius sold 645 shares of the company’s stock in a transaction on Monday, March 9th. The shares were sold at an average price of $485.01, for a total value of $312,831.45. Following the sale, the senior vice president directly owned 1,613 shares of the company’s stock, valued at approximately $782,321.13. This represents a 28.57% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website. Also, EVP Gary Loeb sold 400 shares of Intuitive Surgical stock in a transaction on Monday, May 11th. The shares were sold at an average price of $446.95, for a total transaction of $178,780.00. Following the completion of the sale, the executive vice president owned 6,120 shares of the company’s stock, valued at $2,735,334. This represents a 6.13% decrease in their position. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last ninety days, insiders sold 5,647 shares of company stock worth $2,760,359. Company insiders own 0.60% of the company’s stock.

Institutional Inflows and Outflows

A number of large investors have recently made changes to their positions in the company. Holos Integrated Wealth LLC purchased a new stake in Intuitive Surgical during the fourth quarter worth about $25,000. Newbridge Financial Services Group Inc. increased its holdings in Intuitive Surgical by 300.0% during the fourth quarter. Newbridge Financial Services Group Inc. now owns 44 shares of the medical equipment provider’s stock worth $25,000 after buying an additional 33 shares during the last quarter. Greykasell Wealth Strategies Inc. purchased a new stake in Intuitive Surgical during the third quarter worth about $27,000. Olistico Wealth LLC purchased a new stake in Intuitive Surgical during the fourth quarter worth about $28,000. Finally, Caitlin John LLC purchased a new stake in Intuitive Surgical during the third quarter worth about $30,000. 83.64% of the stock is owned by institutional investors.

Trending Headlines about Intuitive Surgical

Here are the key news stories impacting Intuitive Surgical this week:

• Positive Sentiment: Multiple recent articles highlighted Intuitive Surgical as a potential beneficiary of the AI boom in healthcare, arguing that every robotic procedure creates valuable data that can improve surgeon training, intraoperative guidance, and predictive analytics. Surgical Robotics Meets AI: Intuitive Surgical, Medtronic, and Stryker Are the Sleeper Plays of the Healthcare Boom
• Positive Sentiment: Analysts at Erste Group Bank nudged up their FY2026 and FY2027 earnings estimates for ISRG, reinforcing expectations that earnings growth can continue above consensus. MarketBeat ISRG coverage
• Positive Sentiment: Coverage around da Vinci 5 pointed to strong procedure growth and higher system utilization, suggesting the company’s newest platform is still gaining traction with surgeons and hospitals. Can ISRG’s da Vinci 5 Momentum Sustain Procedure and Utilization Gains?
• Neutral Sentiment: Several bullish opinion pieces said the recent selloff has made Intuitive Surgical look more attractive to growth investors, but these were mostly commentary rather than new company-specific catalysts. Intuitive Surgical Has Dropped 20% This Year. Wall Street Says It’s Time to Buy.

About Intuitive Surgical

Intuitive Surgical, founded in 1995 and headquartered in Sunnyvale, California, is a medical technology company focused on the design, manufacture and service of robotic-assisted surgical systems. The company is best known for its da Vinci surgical systems, which enable minimally invasive procedures by translating a surgeon’s hand movements into finer, scaled motions of small instruments inside the patient. Intuitive’s business centers on supplying hospitals and surgical centers with systems, instruments and related technologies that aim to improve precision, visualization and control in the operating room.

In addition to its core surgical platforms, Intuitive markets a portfolio of reusable and disposable instruments, accessories, and proprietary software, and provides training, servicing and clinical support to its customers.